Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
RBR-8m444qNot yet recruiting
Open-label trial of morphine, ropivacaine, propofol, sufentanil, pancuronium and 1 more in Chronic Coronary Syndrome (CCS) (2 arms), sponsored by Universidade Federal do Rio Grande do Norte. Planned start Mar 2012; status: not yet recruiting.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on RBR-8m444q.